Search research articles
Contact Us
Filters
Showing results (81-90 of 104) with videos related to
Page
of 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2024
Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry
Neeta Pandit-Taskar, Pat B Zanzonico, Milan Grkovski, et al.
International Journal of Cancer
|
August 21, 2023
Stage 4N neuroblastoma before and during the era of anti-G<sub>D2</sub> immunotherapy
Brian H Kushner, Michael P LaQuaglia, Fiorella Iglesias Cardenas, et al.
Pediatric Blood & Cancer
|
September 15, 2006
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies
Stephen W Gilheeney, David C Lyden, Shirley Sgouros, et al.
Practical Radiation Oncology
|
February 4, 2024
Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience
Brianna Conte, Dana L Casey, Kathryn R Tringale, et al.
Pediatric Blood & Cancer
|
November 9, 2022
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
Kathryn R Tringale, Suzanne L Wolden, Dana L Casey, et al.
Journal of Neuro-Oncology
|
November 6, 2009
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
Kim Kramer, Brian H Kushner, Shakeel Modak, et al.
Pediatric Blood & Cancer
|
December 31, 2016
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Oren J Becher, Stephen W Gilheeney, Yasmin Khakoo, et al.
Journal of Pediatric Surgery
|
October 6, 2010
Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections
Mark L Kayton, Edward G Garmey, Nicole M Ishill, et al.
Oncoimmunology
|
September 18, 2018
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
Shakeel Modak, Jean-Benoit Le Luduec, Irene Y Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2007
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8
Kim Kramer, John L Humm, Mark M Souweidane, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 104) with videos related to
Sort By:
Page
of 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2024
Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry
Neeta Pandit-Taskar, Pat B Zanzonico, Milan Grkovski, et al.
International Journal of Cancer
|
August 21, 2023
Stage 4N neuroblastoma before and during the era of anti-G<sub>D2</sub> immunotherapy
Brian H Kushner, Michael P LaQuaglia, Fiorella Iglesias Cardenas, et al.
Pediatric Blood & Cancer
|
September 15, 2006
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies
Stephen W Gilheeney, David C Lyden, Shirley Sgouros, et al.
Practical Radiation Oncology
|
February 4, 2024
Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience
Brianna Conte, Dana L Casey, Kathryn R Tringale, et al.
Pediatric Blood & Cancer
|
November 9, 2022
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
Kathryn R Tringale, Suzanne L Wolden, Dana L Casey, et al.
Journal of Neuro-Oncology
|
November 6, 2009
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
Kim Kramer, Brian H Kushner, Shakeel Modak, et al.
Pediatric Blood & Cancer
|
December 31, 2016
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Oren J Becher, Stephen W Gilheeney, Yasmin Khakoo, et al.
Journal of Pediatric Surgery
|
October 6, 2010
Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections
Mark L Kayton, Edward G Garmey, Nicole M Ishill, et al.
Oncoimmunology
|
September 18, 2018
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
Shakeel Modak, Jean-Benoit Le Luduec, Irene Y Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2007
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8
Kim Kramer, John L Humm, Mark M Souweidane, et al.
Page
of 11